Device Trial Radar · NCT01663051
Evaluation of the Zilver® Vena™ Venous Stent
Last checked: Nov 20, 2026Latest source record: Nov 1, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Nov 2012
Primary completion
Jul 2016
Study completion Jul 2016
Sponsor
- Lead sponsor
- Cook Group IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 13, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective, non-randomized, multi-center study is intended to evaluate the Zilver® Vena™ stent in the treatment of symptomatic iliofemoral venous outflow obstruction.
Conditions
- Iliofemoral Venous Outflow Obstruction
Interventions
Zilver Vena Venous StentDevice
Stenting iliofemoral venous outflow obstruction
Primary outcomes
What the sponsor says the trial is designed to measure.
- Major Adverse EventsTime frame: 1 month
- PatencyTime frame: 12 months
Locations
5 sites in 5 countries. Site status is shown where the registry gives one.
Klinikum Arnsberg GmbH
Arnsberg, Germany
Galway University Hospitals
Galway, Ireland
Hospital Madrid Monteprincipe
Madrid, Spain
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.